• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Cancer & Inflammation
    • Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Cancer & Inflammation
    • Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer

    Volume
    75
    Pagination
    1255 - 1264
    DOI
    10.1158/0008-5472.CAN-14-1801
    Journal
    CANCER RESEARCH
    Issue
    7
    ISSN
    0008-5472
    Metadata
    Show full item record
    Authors
    Milagrel, CS; Gopinathanl, G; Everitt, G; Thompson, RG; Kulbel, H; Zhong, H; Hollingsworth, RE; Grose, R; Bowte, DDL; Hochhauserzl, D
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/7203
    Collections
    • Centre for Cancer & Inflammation [92]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.